Covered recipient · General Payments record
STEPHEN IMBEAU
Allopathic & Osteopathic Physicians Allergy & Immunology
General Payments · PY2018–2024
$3,403.07
- Reported across 173 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $558.75 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Behring | $243.56 | 15 |
| GENZYME CORPORATION | $170.33 | 5 |
| PFIZER INC. | $77.83 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.18 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.76 | 1 |
| Genentech USA, Inc. | $16.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CSL Behring | $7.43 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641091 | CMS |
| CSL Behring | $16.86 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641093 | CMS |
| CSL Behring | $17.28 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641247 | CMS |
| CSL Behring | $8.27 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641151 | CMS |
| CSL Behring | $6.95 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641155 | CMS |
| CSL Behring | $21.60 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641257 | CMS |
| CSL Behring | $34.48 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641259 | CMS |
| CSL Behring | $15.10 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641265 | CMS |
| CSL Behring | $8.90 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641287 | CMS |
| CSL Behring | $38.77 | 10/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641289 | CMS |
| CSL Behring | $10.78 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641305 | CMS |
| CSL Behring | $10.20 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641307 | CMS |
| CSL Behring | $14.32 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641309 | CMS |
| CSL Behring | $27.27 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641311 | CMS |
| CSL Behring | $5.35 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134641313 | CMS |
| Genentech USA, Inc. | $16.09 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133116375 | CMS |
| GENZYME CORPORATION | $26.98 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139647196 | CMS |
| GENZYME CORPORATION | $33.22 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139647212 | CMS |
| GENZYME CORPORATION | $35.67 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139647232 | CMS |
| GENZYME CORPORATION | $39.37 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139647234 | CMS |
| GENZYME CORPORATION | $35.09 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139647242 | CMS |
| Novartis Pharmaceuticals Corporation | $24.76 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086915311 | CMS |
| PFIZER INC. | $21.63 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131032071 | CMS |
| PFIZER INC. | $18.20 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131046771 | CMS |
| PFIZER INC. | $20.80 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131344613 | CMS |
| PFIZER INC. | $17.20 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131746066 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.18 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137583810 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.